Skip to main content
. 2018 May 8;8:7289. doi: 10.1038/s41598-018-25661-9

Table 4.

Comparison of the antimicrobial susceptibilities of biofilm-forming and non-biofilm-forming Acinetobacter baumannii isolates.

Antimicrobial agent Biofilm-forming isolates (n = 71) Non-biofilm-forming isolates (n = 202) p value b
Resistance, no. (%) MIC90 (µg/mL) Resistance, no. (%) MIC90
(µg/mL)
Amikacin 44 (62.0) >2048 151 (74.8) >2048 0.040
Gentamicin 57 (80.0) >2048 181 (89.6) >2048 0.043
Ceftazidime 56 (78.9) 512 186 (92.1) 1024 0.003
Cefepime or cefpirome 48 (67.6) 128 157 (77.7) 256 0.009
Piperacillin/tazobactam 52 (73.2) 4096/4 163 (80.7) >4096/4 0.187
Ampicillin/sulbactam 46 (64.8) 64/32 141 (69.8) 128/64 0.434
Ciprofloxacin 55 (77.5) 256 187 (92.6) 512 0.001
Imipenem 39 (54.9) 64 139 (78.1) 64 0.035
Meropenem 39 (54.9) 64 142 (78.5) 128 0.018
Tigecycline 19 (26.8) 4 39 (19.3) 4 0.187
Colistin 0 2 0 2
Multidrug resistancea 58 (81.7) 188 (93.1) 0.006

aDefinition: resistance to three or more of the following classes of antimicrobial agents: anti-pseudomonal cephalosporins, anti-pseudomonal carbapenems, ampicillin/sulbactam, fluoroquinolones and aminoglycosides.

bp value: The difference in resistance rate to antibiotics between biofilm-forming isolates and non-biofilm-forming isolates.